PEG (2000) -C-DMG
PEG (2000) -C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol. PEG (2000) -C-DMG can be used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of siRNA[1].
Product Specifications
CAS Number
1443687-74-8
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCCCCCCCCCCCCC(OC(COC(NCCCOCCOC)=O)COC(CCCCCCCCCCCCC)=O)=O.[n]
Molecular Weight
2600 (Approximately)
References & Citations
[1]Hobo W, , et al. Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation. Cancer Immunol Immunother. 2013 Feb;62 (2) :285-97.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
FH64765-01 100 g
4- (1-Hydroxy-1-methylethyl) -2-propyl-1H-imidazole-5-carboxylic acid ethyl ester
Sign In for Pricing
View Details FH64765-02 250 g
4- (1-Hydroxy-1-methylethyl) -2-propyl-1H-imidazole-5-carboxylic acid ethyl ester
Sign In for Pricing
View Details FH64765-03 500 g
4- (1-Hydroxy-1-methylethyl) -2-propyl-1H-imidazole-5-carboxylic acid ethyl ester
Sign In for Pricing
View Details 